The Revlar Labs approach to infectious disease diagnostics stands to disrupt the commercial and laboratory markets. Diagnostic efforts include Covid-targeted assays using patented biosensors in vitro, alongside on-site and Point of Care diagnostic solutions.
Bypass the challenges associated with typical PCR and rapid antigen tests for COVID. Revlar Labs has designed a better diagnostic solution offering speed, simplicity and sensitivity with the ability for labs to scale accurate, rapid-results tests.
CLIA LAB solutions including
Hinged Peptid molecular nanoswitches
Covid-targeted assay development
High-Throughput Lab (HTL) kits
ON-SITE COVID SOLUTIONS for
Point of Care providers
Venues
Employers
School Campuses
CONTACT
Tony@Revlarlabs.com
Company Details
- Employees
- 4
- Founded
- 2019
- Address
- Los Angeles, Ca, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.revlardx.com
- Keywords
- Point of Care, Molecular Assay, Covid Diagnostics, CLIA Lab, Pathology, Infectious Disease, BioTech, Corona Virus Diagnostics, SARS-Cov2.
- HQ
- Los Angeles, CA
Revlar Diagnostics Questions
Revlar Diagnostics's website is http://www.revlardx.com
Revlar Diagnostics's LinkedIn profile is https://www.linkedin.com/company/revlardiagnostics
Revlar Diagnostics has
4 employees.
View email and phone details for 4
employees at Revlar Diagnostics.
Revlar Diagnostics's industry is
Biotechnology Research
Revlar Diagnostics's top competitors are
Yesgrow,
Effervescence Dx,
Aitive Cybersecurity,
Us4 Capital,
Blomberg Meddev, Llc,
Tailored 385,
Animal Diagnostics Inc,
Connectdoc,
Premieru Med,
South County Anesthesia Associates, Llc.
Revlar Diagnostics's categories are Biotechnology Research
Revlar Diagnostics's founding year is 2019
